1394373-84-2

Basic information

• Product Name: (3R,3aR,6R,6aR)-6-[[5-(4-bromophenyl)-6-chloro-1H-imidazo[4,5-b]pyridin-2-yl]oxy]-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-ol
• Synonyms: (3R,3aR,6R,6aR)-6-[[5-(4-bromophenyl)-6-chloro-1H-imidazo[4,5-b]pyridin-2-yl]oxy]-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-ol
• CAS NO: 1394373-84-2
• Molecular Weight: 452.692
• Mol File: 1394373-84-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (3R,3aR,6R,6aR)-6-[[5-(4-bromophenyl)-6-chloro-1H-imidazo[4,5-b]pyridin-2-yl]oxy]-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (3R,3aR,6R,6aR)-6-[[5-(4-bromophenyl)-6-chloro-1H-imidazo[4,5-b]pyridin-2-yl]oxy]-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-ol(1394373-84-2)
• EPA Substance Registry System: (3R,3aR,6R,6aR)-6-[[5-(4-bromophenyl)-6-chloro-1H-imidazo[4,5-b]pyridin-2-yl]oxy]-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-ol(1394373-84-2)

Safety Data

• Hazardous Substances Data: 1394373-84-2(Hazardous Substances Data)

Upstream product

• 1394373-61-5 (3R,3aR,6R,6aR)-6-[5-(4-bromophenyl)-6-chloro-1-(2-trimethylsilylethoxymethyl)imidazo[4,5-b]pyridin-2-yl]oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-ol 
• 1394373-18-2 6-chloro-5-iodo-2-(methylsulfonyl)-1H-imidazo[4,5-b]pyridine 
• 1394373-25-1 6-chloro-5-iodo-1,3-dihydro-2H-imidazo [4,5-b] pyridine-2-thione 
• 1394373-23-9 5-chloro-6-iodopyridine-2,3-diamine 
• 1394373-21-7 5-chloro-6-iodo-3-nitropyridin-2-amine 
• 203794-33-6 2-amino-5,6-dichloro-3-nitropyridine 
• 5409-39-2 2-amino-5-chloro-3-nitropyridine 

Downstream Products

• 1394372-86-1 (3R,3aR,6R,6aR)-6-((6-chloro-5-(4-(piperidin-4-ylethynyl)phenyl)-1H-imidazo[4,5-b]pyridin-2-yl)oxy)hexahydrofuro[3,2-b]furan-3-ol 
• 1394371-78-8 (3R,3aR,6R,6aR)-6-[[6-chloro-5-[4-[4-(1-methylimidazol-2-yl)phenyl]phenyl]-1H-imidazo[4,5-b]pyridin-2-yl]oxy]-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-ol 

Relevant articles and documents

NOVEL AZABENZIMIDAZOLE HEXAHYDROFURO[E,2-B]FURAN DERIVATIVES

Novel compounds of the structural formula (I) are activators of AMP-protein kinase and may be useful in the treatment, prevention and suppression of diseases mediated by the AMPK activated protein kinase. The compounds of the present invention may be usef